Full Press Release Details
| Corporate Relationship Department | National Stock Exchange of India Ltd. | |
| BSE Limited | "Exchange Plaza" | |
| Dalal Street, Fort | Bandra-Kurla Complex, Bandra (East), | |
| Mumbai - 400 001 | Mumbai - 400 051 | |
| Fax Nos.: 022-22723121 / 22723719 / | Fax Nos.: 022-26598120/ 26598237/ | |
| Scrip Code: 500124 | Scrip Code: DRREDDY-EQ |
Further to our intimation dated November
29, 2017 with regard to U.S. Securities Class Action Lawsuit, we would like to inform you that an amended complaint has been filed
by the lead plaintiff wherein, our Chairman, COO and Dr. Reddy's Laboratories Inc., a wholly-owned subsidiary in the U.S.
have been added as defendants.
As intimated earlier the Company believes
that the asserted claims are without merit and intends to vigorously defend itself against the allegations.
This is for your information and record.
| With regards, | |
| /s/ Sandeep Poddar | |
| Sandeep Poddar | |
| Company Secretary |
CC:- New York Stock Exchange Inc.(Stock Code :RDY)